Logo image of JBLU

JETBLUE AIRWAYS CORP (JBLU) Stock Fundamental Analysis

NASDAQ:JBLU - Nasdaq - US4771431016 - Common Stock - Currency: USD

4.47  -0.27 (-5.7%)

After market: 4.4802 +0.01 (+0.23%)

Fundamental Rating

2

Taking everything into account, JBLU scores 2 out of 10 in our fundamental rating. JBLU was compared to 23 industry peers in the Passenger Airlines industry. JBLU has a bad profitability rating. Also its financial health evaluation is rather negative. JBLU does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

JBLU had negative earnings in the past year.
In the past year JBLU had a positive cash flow from operations.
JBLU had negative earnings in each of the past 5 years.
Of the past 5 years JBLU 4 years had a positive operating cash flow.
JBLU Yearly Net Income VS EBIT VS OCF VS FCFJBLU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B

1.2 Ratios

The Return On Assets of JBLU (-1.68%) is comparable to the rest of the industry.
With a Return On Equity value of -11.74%, JBLU perfoms like the industry average, outperforming 52.17% of the companies in the same industry.
Industry RankSector Rank
ROA -1.68%
ROE -11.74%
ROIC N/A
ROA(3y)-3.24%
ROA(5y)-4.23%
ROE(3y)-16.52%
ROE(5y)-17.71%
ROIC(3y)N/A
ROIC(5y)N/A
JBLU Yearly ROA, ROE, ROICJBLU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 -30

1.3 Margins

The Gross Margin of JBLU (67.80%) is better than 86.96% of its industry peers.
In the last couple of years the Gross Margin of JBLU has remained more or less at the same level.
JBLU does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 67.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.27%
GM growth 5Y-1.02%
JBLU Yearly Profit, Operating, Gross MarginsJBLU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

2

2. Health

2.1 Basic Checks

JBLU does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, JBLU has more shares outstanding
JBLU has more shares outstanding than it did 5 years ago.
JBLU has a worse debt/assets ratio than last year.
JBLU Yearly Shares OutstandingJBLU Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
JBLU Yearly Total Debt VS Total AssetsJBLU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

JBLU has an Altman-Z score of 0.68. This is a bad value and indicates that JBLU is not financially healthy and even has some risk of bankruptcy.
JBLU's Altman-Z score of 0.68 is in line compared to the rest of the industry. JBLU outperforms 47.83% of its industry peers.
A Debt/Equity ratio of 3.31 is on the high side and indicates that JBLU has dependencies on debt financing.
JBLU has a Debt to Equity ratio of 3.31. This is comparable to the rest of the industry: JBLU outperforms 47.83% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.31
Debt/FCF N/A
Altman-Z 0.68
ROIC/WACCN/A
WACC5.3%
JBLU Yearly LT Debt VS Equity VS FCFJBLU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 1.01 indicates that JBLU should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.01, JBLU belongs to the top of the industry, outperforming 91.30% of the companies in the same industry.
JBLU has a Quick Ratio of 1.01. This is a bad value and indicates that JBLU is not financially healthy enough and could expect problems in meeting its short term obligations.
JBLU has a better Quick ratio (0.97) than 91.30% of its industry peers.
Industry RankSector Rank
Current Ratio 1.01
Quick Ratio 0.97
JBLU Yearly Current Assets VS Current LiabilitesJBLU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

3

3. Growth

3.1 Past

JBLU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -57.14%.
JBLU shows a decrease in Revenue. In the last year, the revenue decreased by -3.02%.
JBLU shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.77% yearly.
EPS 1Y (TTM)-57.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-37.21%
Revenue 1Y (TTM)-3.02%
Revenue growth 3Y15.41%
Revenue growth 5Y2.77%
Sales Q2Q%-3.12%

3.2 Future

JBLU is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.38% yearly.
Based on estimates for the next years, JBLU will show a small growth in Revenue. The Revenue will grow by 4.06% on average per year.
EPS Next Y-131.91%
EPS Next 2Y-21.58%
EPS Next 3Y17.38%
EPS Next 5YN/A
Revenue Next Year-2.18%
Revenue Next 2Y2.74%
Revenue Next 3Y4.06%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
JBLU Yearly Revenue VS EstimatesJBLU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
JBLU Yearly EPS VS EstimatesJBLU Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

JBLU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year JBLU is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
JBLU Price Earnings VS Forward Price EarningsJBLU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, JBLU is valued a bit more expensive than 60.87% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.64
JBLU Per share dataJBLU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

JBLU's earnings are expected to grow with 17.38% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-21.58%
EPS Next 3Y17.38%

More info and screens

0

5. Dividend

5.1 Amount

JBLU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

JETBLUE AIRWAYS CORP

NASDAQ:JBLU (6/13/2025, 8:12:29 PM)

After market: 4.4802 +0.01 (+0.23%)

4.47

-0.27 (-5.7%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)04-29 2025-04-29/bmo
Earnings (Next)07-28 2025-07-28/bmo
Inst Owners89.38%
Inst Owner Change0.68%
Ins Owners10.36%
Ins Owner Change14.57%
Market Cap1.58B
Analysts47.27
Price Target4.55 (1.79%)
Short Float %20.66%
Short Ratio2.22
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.78%
Min EPS beat(2)5.75%
Max EPS beat(2)33.81%
EPS beat(4)4
Avg EPS beat(4)61.77%
Min EPS beat(4)5.75%
Max EPS beat(4)169.56%
EPS beat(8)6
Avg EPS beat(8)30.82%
EPS beat(12)8
Avg EPS beat(12)-5.16%
EPS beat(16)12
Avg EPS beat(16)0.2%
Revenue beat(2)0
Avg Revenue beat(2)-1.64%
Min Revenue beat(2)-2.33%
Max Revenue beat(2)-0.96%
Revenue beat(4)0
Avg Revenue beat(4)-1.23%
Min Revenue beat(4)-2.33%
Max Revenue beat(4)-0.74%
Revenue beat(8)0
Avg Revenue beat(8)-1.49%
Revenue beat(12)0
Avg Revenue beat(12)-1.61%
Revenue beat(16)2
Avg Revenue beat(16)-1.3%
PT rev (1m)-0.86%
PT rev (3m)-26.68%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-649.04%
EPS NY rev (1m)0%
EPS NY rev (3m)-166.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-12.01%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.01%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.17
P/FCF N/A
P/OCF 29.33
P/B 0.65
P/tB 0.77
EV/EBITDA 9.64
EPS(TTM)-0.88
EYN/A
EPS(NY)-1.06
Fwd EYN/A
FCF(TTM)-3.63
FCFYN/A
OCF(TTM)0.15
OCFY3.41%
SpS25.99
BVpS6.9
TBVpS5.77
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.68%
ROE -11.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 67.8%
FCFM N/A
ROA(3y)-3.24%
ROA(5y)-4.23%
ROE(3y)-16.52%
ROE(5y)-17.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.27%
GM growth 5Y-1.02%
F-Score5
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 3.31
Debt/FCF N/A
Debt/EBITDA 14.58
Cap/Depr 201.5%
Cap/Sales 14.55%
Interest Coverage N/A
Cash Conversion 9.73%
Profit Quality N/A
Current Ratio 1.01
Quick Ratio 0.97
Altman-Z 0.68
F-Score5
WACC5.3%
ROIC/WACCN/A
Cap/Depr(3y)199.72%
Cap/Depr(5y)186.25%
Cap/Sales(3y)13.36%
Cap/Sales(5y)16.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-57.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-37.21%
EPS Next Y-131.91%
EPS Next 2Y-21.58%
EPS Next 3Y17.38%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.02%
Revenue growth 3Y15.41%
Revenue growth 5Y2.77%
Sales Q2Q%-3.12%
Revenue Next Year-2.18%
Revenue Next 2Y2.74%
Revenue Next 3Y4.06%
Revenue Next 5YN/A
EBIT growth 1Y-86.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year286.31%
EBIT Next 3Y92.45%
EBIT Next 5YN/A
FCF growth 1Y-203.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-89.94%
OCF growth 3Y-55.57%
OCF growth 5Y-36.98%